These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24151948)

  • 21. Treat to target in managing inflammatory arthritis.
    Mian A; Scott DL
    Br J Hosp Med (Lond); 2015 Jan; 76(1):31-4. PubMed ID: 25585181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of rheumatoid arthritis in Spain (emAR II). Clinical characteristics of the patients.
    Maese J; García De Yébenes MJ; Carmona L; Hernández-García C;
    Reumatol Clin; 2012; 8(5):236-42. PubMed ID: 22608957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Obstacles to the implementation of the treat-to-target strategy for rheumatoid arthritis in clinical practice in Japan.
    Kaneko Y; Koike T; Oda H; Yamamoto K; Miyasaka N; Harigai M; Yamanaka H; Ishiguro N; Tanaka Y; Takeuchi T
    Mod Rheumatol; 2015 Jan; 25(1):43-9. PubMed ID: 24950169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Results from controlled clinical trials: how relevant for clinical practice?
    Kvien TK; Mikkelsen K; Nordvåg BY
    J Rheumatol; 2003 Jun; 30(6):1135-7. PubMed ID: 12784381
    [No Abstract]   [Full Text] [Related]  

  • 25. [Management of patients with rheumatoid arthritis].
    Thomas D
    Ther Umsch; 2005 May; 62(5):281-4. PubMed ID: 15945217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treat to target in rheumatoid arthritis].
    Casado G; Alba P
    Rev Fac Cien Med Univ Nac Cordoba; 2010; 67(4):133-4. PubMed ID: 21843436
    [No Abstract]   [Full Text] [Related]  

  • 27. Early rheumatoid arthritis -- is there a window of opportunity?
    Cush JJ
    J Rheumatol Suppl; 2007 Nov; 80():1-7. PubMed ID: 17985417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Do changes in prescription practice in patients with rheumatoid arthritis treated with biological agents affect treatment response and adherence to therapy? Results from the nationwide Danish DANBIO Registry.
    Hetland ML; Lindegaard HM; Hansen A; Pødenphant J; Unkerskov J; Ringsdal VS; Østergaard M; Tarp U
    Ann Rheum Dis; 2008 Jul; 67(7):1023-6. PubMed ID: 18272669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacological management of rheumatoid arthritis: the state of the art and the future perspective].
    Kameda H; Takeuchi T
    Nihon Rinsho; 2013 Jul; 71(7):1166-71. PubMed ID: 23961662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prescribing trends for targeted therapies in rheumatoid arthritis among rheumatologists in Southern California, 2008-2010.
    Bagheri S; Wallace DJ
    Arthritis Rheum; 2011 Nov; 63(11):3641. PubMed ID: 21769837
    [No Abstract]   [Full Text] [Related]  

  • 31. Treat to target strategy in rheumatoid arthritis: real benefits.
    Cardiel MH
    Reumatol Clin; 2013; 9(2):101-5. PubMed ID: 22985804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treating rheumatoid arthritis to target: physician and patient adherence issues in contemporary rheumatoid arthritis therapy.
    Wabe N; Wiese MD
    J Eval Clin Pract; 2017 Jun; 23(3):486-493. PubMed ID: 27650675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is it time to optimize anchor therapy for rheumatoid arthritis?
    Bijlsma JW
    Rheumatology (Oxford); 2012 Jun; 51 Suppl 4():iv1-2. PubMed ID: 22685270
    [No Abstract]   [Full Text] [Related]  

  • 34. Barriers to optimal disease control for rheumatoid arthritis patients with moderate and high disease activity.
    Tymms K; Zochling J; Scott J; Bird P; Burnet S; de Jager J; Griffiths H; Nicholls D; Roberts L; Arnold M; Littlejohn G
    Arthritis Care Res (Hoboken); 2014 Feb; 66(2):190-6. PubMed ID: 23983001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of specialists in managing established rheumatoid arthritis.
    Scott DL; Symmons DP
    Rheumatology (Oxford); 2008 Mar; 47(3):237-8. PubMed ID: 18245801
    [No Abstract]   [Full Text] [Related]  

  • 36. [The usefulness of the latest diagnostic and therapeutic criteria ACR/EULAR in the treatment of rheumatoid arthritis].
    Pytel A; Wrzosek Z; Demczyszak I; Brzyski J
    Wiad Lek; 2012; 65(4):225-31. PubMed ID: 23654143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of rheumatoid arthritis: strategies for achieving optimal outcomes.
    Gibofsky A; Yazici Y
    Ann Rheum Dis; 2010 Jun; 69(6):941-2. PubMed ID: 20498219
    [No Abstract]   [Full Text] [Related]  

  • 38. Trends in treatment and outcomes of rheumatoid arthritis in Germany 1997-2007: results from the National Database of the German Collaborative Arthritis Centres.
    Ziegler S; Huscher D; Karberg K; Krause A; Wassenberg S; Zink A
    Ann Rheum Dis; 2010 Oct; 69(10):1803-8. PubMed ID: 20447953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Early recognition of rheumatoid arthritis].
    van der Helm-van Mil AH; Posthumus MD
    Ned Tijdschr Geneeskd; 2011; 155(30-31):A2902. PubMed ID: 22085506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rheumatoid arthritis: guidelines for emerging therapies.
    Blumberg SN; Fox DA
    Am J Manag Care; 2001 Jun; 7(6):617-26. PubMed ID: 11439735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.